LDL sensitizes platelets through early activation of p38MAPK, which promotes the release of arachidonic acid and subsequent thromboxane A2 synthesis.
No takes yet. Share an insight, caveat, or question.
Should not alter clinical practice; leaves open whether apoB modification attenuates LDL-driven platelet activation in humans.
Hackeng et al. (1999) studied this question.